| Name | Title | Contact Details |
|---|
Independent Forensics Of Illinois is a Hillside, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medytox Solutions, Inc. develops and delivers cutting-edge testing and reporting technology and systems, providing an affordable and superior service to medical providers. In turn, our medical provider clients are able to provide better and more cost-effective patient care. Medytox offers its clients a complete solution, with faster turnaround times and more reliable and accurate results, in a manner that is safe, secure and HIPAA-compliant in all respects. We conduct our testing on the most accurate and advanced equipment available, using proven methodologies to provide superior results, while supporting our clients with personnel, equipment and turn-key services dedicated to providing them with the latitude to offer an optimized level of enhanced patient care.
908 Devices, is democratizing chemical analysis by way of mass spectrometry, offering point-of-need chemical analysis devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices. These purpose-built and user-centric devices serve a range of industries including safety and security, oil & gas, life sciences and other applied markets. 908 Devices is headquartered in the heart of Boston where they research, design and manufacture innovative products based on High Pressure Mass Spectrometry (HPMS).
Diadexus is a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, providing healthcare providers with actionable information for managing patients. We pioneered the testing of Lp-PLA2 (lipoprotein-associated phospholipase A2), a marker of vascular-specific inflammation that provides new information, over and above traditional risk factors measured in a lipid panel, and has over a decade of peer-reviewed literature validating this biomarker`s utility. Our products are the only two FDA-cleared tests to measure Lp-PLA2: The PLAC® Test ELISA Kit first cleared by the FDA in 2003 and The PLAC® Test for Lp-PLA2 Activity cleared in December 2014. Our pipeline of advanced cardiac biomarkers includes biomarkers for heart failure, proADM, proET-1 and proANP. Each marker gives distinct, additive information for healthcare providers over currently available markers. Diadexus also provides services to pharmaceutical partners to address the need to incorporate biomarkers in clinical development. Our portfolio of advanced cardiac biomarkers is available to be paired with novel therapeutics in development for indications where cardiovascular risk information would provide valuable insights. This information can be used by pharmaceutical companies in targeting the appropriate patient population and understanding the potential long-term side effects for their therapeutics, potentially avoiding long-term follow up studies.
Trocolab is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.